Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports.
aerosol foam
betamethasone dipropionate
calcipotriol
psoriasis
Journal
Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
04
2022
accepted:
23
05
2022
entrez:
22
7
2022
pubmed:
23
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
Psoriasis is a chronic inflammatory disease affecting about 100 million people worldwide. Around 80% of patients can be treated with topical agents, most commonly corticosteroids and vitamin D analogues. A topical foam formulation of calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) (Cal/BD foam; Enstilar
Identifiants
pubmed: 35864998
doi: 10.7573/dic.2022-4-3
pii: dic-2022-4-3
pmc: PMC9267161
pii:
doi:
Types de publication
Case Reports
Langues
eng
Informations de copyright
Copyright © 2022 Apalla Z, Perrussel M, Rallis E.
Déclaration de conflit d'intérêts
Disclosure and potential conflicts of interest: ZA, MP and ER received funding from LEO Pharma for the case studies presented here. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/07/dic.2022-4-3-COI.pdf
Références
Expert Opin Drug Saf. 2020 Apr;19(4):423-432
pubmed: 32243212
J Drugs Dermatol. 2016 Aug 1;15(8):981-7
pubmed: 27537999
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):60-67
pubmed: 34543474
J Clin Aesthet Dermatol. 2016 Feb;9(2):34-41
pubmed: 27313822
J Dermatolog Treat. 2020 Dec;31(8):776-785
pubmed: 31122090
Skinmed. 2017 Apr 01;15(2):119-124
pubmed: 28528605
Dermatology. 2017;233(6):425-434
pubmed: 29502110
Dermatol Pract Concept. 2021 May 20;11(3):e2021056
pubmed: 34123560
Eur J Dermatol. 2018 Jun 1;28(3):356-363
pubmed: 29952297
J Am Acad Dermatol. 2021 Feb;84(2):432-470
pubmed: 32738429
J Drugs Dermatol. 2015 Dec;14(12):1468-77
pubmed: 26659941
BMJ. 2020 May 28;369:m1590
pubmed: 32467098
J Am Acad Dermatol. 2003 Jan;48(1):48-54
pubmed: 12522370
Dermatol Ther. 2021 Sep;34(5):e15077
pubmed: 34333823
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):119-126
pubmed: 27531752
Lancet. 2007 Jul 21;370(9583):263-271
pubmed: 17658397
J Dermatolog Treat. 2022 Jun;33(4):2118-2128
pubmed: 33945378
J Invest Dermatol. 2011 Feb;131(2):283-5
pubmed: 21228808
J Dermatolog Treat. 2022 Jun;33(4):2297-2304
pubmed: 34365872
Clin Cosmet Investig Dermatol. 2019 Sep 17;12:699-705
pubmed: 31571970
J Am Acad Dermatol. 2021 May;84(5):1269-1277
pubmed: 32950546
J Dermatolog Treat. 2022 Feb;33(1):111-120
pubmed: 32091278
J Drugs Dermatol. 2021 Apr 1;20(4):436-441
pubmed: 33852252
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1116-1123
pubmed: 30916417
J Dermatolog Treat. 2022 Jun;33(4):2234-2240
pubmed: 34130573
J Dermatolog Treat. 2019 Mar;30(2):158-169
pubmed: 29737895